Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

Research output: Contribution to journalReview article

381 Citations (Scopus)

Abstract

Diabetic nephropathy leading to kidney failure is a major complication of both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus, and glomerular structural lesions (especially expansion of the mesangium) may constitute the principal cause of decline in kidney function experienced by a significant fraction of diabetic patients. Although the biochemical bases of these mesangial abnormalities remain unknown, an understanding of the natural history of diabetic nephropathy from a combined structural and functional approach can lead to greater pathophysiological insight. Work in animals has supported the concept that the metabolic disturbances of diabetes mellitus cause diabetic nephropathy, with structural and functional lesions prevented or reversed with improved or normalized glycemic control. Additional research must address this fundamental issue in humans, especially the response of advancing mesangial lesions to improved glycemic control. Factors not directly related to the metabolic perturbations of diabetes may serve to accelerate or diminish the pathophysiological processes of diabetic nephropathy. The elucidation and management of these factors, when coupled with improved glycemic control, may moderate the development or progression of diabetic kidney lesions in humans.

Original languageEnglish (US)
Pages (from-to)1077-1081
Number of pages5
JournalDiabetes
Volume38
Issue number9
DOIs
StatePublished - Jan 1 1989

Fingerprint

Diabetic Nephropathies
Kidney
Type 2 Diabetes Mellitus
Renal Insufficiency
Diabetes Mellitus
Insulin
Research

Cite this

Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. / Steffes, Michael W; Chavers, Blanche M; Mauer, Michael; Osterby, R.

In: Diabetes, Vol. 38, No. 9, 01.01.1989, p. 1077-1081.

Research output: Contribution to journalReview article

@article{b35f043023c0424dbf47e1db0bde2d9d,
title = "Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients",
abstract = "Diabetic nephropathy leading to kidney failure is a major complication of both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus, and glomerular structural lesions (especially expansion of the mesangium) may constitute the principal cause of decline in kidney function experienced by a significant fraction of diabetic patients. Although the biochemical bases of these mesangial abnormalities remain unknown, an understanding of the natural history of diabetic nephropathy from a combined structural and functional approach can lead to greater pathophysiological insight. Work in animals has supported the concept that the metabolic disturbances of diabetes mellitus cause diabetic nephropathy, with structural and functional lesions prevented or reversed with improved or normalized glycemic control. Additional research must address this fundamental issue in humans, especially the response of advancing mesangial lesions to improved glycemic control. Factors not directly related to the metabolic perturbations of diabetes may serve to accelerate or diminish the pathophysiological processes of diabetic nephropathy. The elucidation and management of these factors, when coupled with improved glycemic control, may moderate the development or progression of diabetic kidney lesions in humans.",
author = "Steffes, {Michael W} and Chavers, {Blanche M} and Michael Mauer and R. Osterby",
year = "1989",
month = "1",
day = "1",
doi = "10.2337/diab.38.9.1077",
language = "English (US)",
volume = "38",
pages = "1077--1081",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients

AU - Steffes, Michael W

AU - Chavers, Blanche M

AU - Mauer, Michael

AU - Osterby, R.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Diabetic nephropathy leading to kidney failure is a major complication of both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus, and glomerular structural lesions (especially expansion of the mesangium) may constitute the principal cause of decline in kidney function experienced by a significant fraction of diabetic patients. Although the biochemical bases of these mesangial abnormalities remain unknown, an understanding of the natural history of diabetic nephropathy from a combined structural and functional approach can lead to greater pathophysiological insight. Work in animals has supported the concept that the metabolic disturbances of diabetes mellitus cause diabetic nephropathy, with structural and functional lesions prevented or reversed with improved or normalized glycemic control. Additional research must address this fundamental issue in humans, especially the response of advancing mesangial lesions to improved glycemic control. Factors not directly related to the metabolic perturbations of diabetes may serve to accelerate or diminish the pathophysiological processes of diabetic nephropathy. The elucidation and management of these factors, when coupled with improved glycemic control, may moderate the development or progression of diabetic kidney lesions in humans.

AB - Diabetic nephropathy leading to kidney failure is a major complication of both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus, and glomerular structural lesions (especially expansion of the mesangium) may constitute the principal cause of decline in kidney function experienced by a significant fraction of diabetic patients. Although the biochemical bases of these mesangial abnormalities remain unknown, an understanding of the natural history of diabetic nephropathy from a combined structural and functional approach can lead to greater pathophysiological insight. Work in animals has supported the concept that the metabolic disturbances of diabetes mellitus cause diabetic nephropathy, with structural and functional lesions prevented or reversed with improved or normalized glycemic control. Additional research must address this fundamental issue in humans, especially the response of advancing mesangial lesions to improved glycemic control. Factors not directly related to the metabolic perturbations of diabetes may serve to accelerate or diminish the pathophysiological processes of diabetic nephropathy. The elucidation and management of these factors, when coupled with improved glycemic control, may moderate the development or progression of diabetic kidney lesions in humans.

UR - http://www.scopus.com/inward/record.url?scp=0024422014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024422014&partnerID=8YFLogxK

U2 - 10.2337/diab.38.9.1077

DO - 10.2337/diab.38.9.1077

M3 - Review article

VL - 38

SP - 1077

EP - 1081

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -